- Home
- GHI vs ENGN Comparison
GHI vs ENGN Comparison
Compare GHI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHI
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Company Overview
Basic Information| Metric | GHI | ENGN |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | Canada |
| Employees | N/A | 82 |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 605.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GHI | ENGN |
|---|---|---|
| Price | $6.80 | $9.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $13.00 | ★ $22.71 |
| AVG Volume (30 Days) | 183.0K | ★ 259.1K |
| Earning Date | 11-06-2025 | 12-22-2025 |
| Dividend Yield | ★ 21.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $26,247,399.00 | N/A |
| Revenue This Year | $201.02 | N/A |
| Revenue Next Year | $2.87 | N/A |
| P/E Ratio | $41.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.01 | $2.65 |
| 52 Week High | $13.29 | $11.14 |
Technical Indicators
Market Signals| Indicator | GHI | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 57.72 |
| Support Level | $6.99 | $7.57 |
| Resistance Level | $7.35 | $9.81 |
| Average True Range (ATR) | 0.34 | 0.72 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 42.62 | 57.71 |
Price Performance
Historical ComparisonAbout GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.